StonvexLoading…
StonvexStonvexStonvexCore line items from FCFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.67B | $1.51B | $1.38B | $1.26B |
Operating Income | $447.56M | $342.78M | $292.85M | $323.63M |
Net Income | $330.38M | $258.81M | $219.30M | $253.50M |
EPS (Diluted) | $7.42 | $5.73 | $4.80 | $5.36 |
Total Assets | $5.30B | $4.48B | $4.29B | $3.90B |
Total Liabilities | $3.02B | $2.42B | $2.29B | $2.03B |
Cash & Equivalents | $125.20M | $175.09M | $127.02M | $117.33M |
Free Cash Flow OCF − CapEx | $531.04M | $471.71M | $355.99M | $433.72M |
Shares Outstanding | 43.98M | 44.75M | 45.11M | 46.29M |